Luigi Liguori

7PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 04, 2025
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.

Giovanna Polcaro, Luigi Liguori, Valentina Manzo

|Dec 22, 2023
Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review.

Angelo Luciano, Luigi Liguori, Giovanna Polcaro

|Nov 25, 2023
Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series.

Luigi Liguori, Angelo Luciano, Giovanna Polcaro

|Nov 14, 2023
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19.

Francesco Sabbatino, Pasquale Pagliano, Carmine Sellitto

|Feb 25, 2023
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches.

Valeria Conti, Graziamaria Corbi, Francesco Sabbatino

|Nov 26, 2022
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors.

Luigi Liguori, Giovanna Polcaro, Annunziata Nigro

Pageof 2

Frequent Collaborators

6 joint publications

Francesco Sabbatino

3 joint publications

Valeria Conti

3 joint publications

Carmine Sellitto

3 joint publications

Alessandro Ottaiano